Live Quote · NASDAQCRVSHealthcare· Biotechnology

Corvus Pharmaceuticals, Inc.

$9.67▼ 3.40%($-0.34)
MKT CAP $815.69MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
51/100
▌ Mixed
67
Valuation
20
Profitability
60
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRVS research report →

Analyst Price Target
$27.00+179.2% vs. today

Range $27 – $27

Analyst RatingBuy
12 Buy1 Hold0 Sell

Price Chart

+13.63% · this period
$25.52$16.01$6.50Nov 20May 26Nov 20
52-Week Range16% of range
Low
$6.39
Current
$9.67
High
$26.95